Resolution of Insulin-Requiring Diabetes after Cessation of Chemotherapy for Tuberculosis

Chan J.C. , Cockram C.S. , Critchley J.A. Drug-induced disorders of glucose metabolism. Mechanisms and management. Drug Saf 1996; 15: 135–57

Kane J.M. , Barrett E.J. , Casey D.E. . Metabolic effects of treatment with atypical antipsychotics. J Clin Psychiatry 2004; 65: 1447–55

Woerle H.J. , Mariuz P.R. , Meyer C. . Mechanisms for the deterioration in glucose tolerance associated with HIV protease inhibitor regimens. Diabetes 2003; 52: 918–25

Basoglu O.K. , Bacakoglu F. , Cok G. , Sayiner A. , Ates M. The oral glucose tolerance test in patients with respiratory infections. Monaldi Arch Chest Dis 1999; 54: 307–10

Ismail Y. Pulmonary tuberculosis—a review of clinical features and diagnosis in 232 cases. Med J Malaysia 2004; 59: 56–64

Ponce-De-Leon A. , Garcia-Garcia Md Mde L. , Garcia-Sancho M.C. . Tuberculosis and diabetes in southern Mexico. Diab Care 2004; 27: 1584–90

Kihara Y. , Otsuki M. Interaction of gliclazide and rifampicin. Diab Care 2000; 23: 1204–5

Self T.H. , Tsui S.J. , Fowler J.W. Interaction of rifampin and glyburide. Chest 1989; 96: 1443–4

Atkin S.L. , Masson E.A. , Bodmer C.W. , Walker B.A. , White M.C. Increased insulin requirement in a patient with type 1 diabetes treated with rifampicin. Diab Med 1993; 10: 392

Takasu N. , Yamada T. , Miura H. . Rifampicin-induced early phase hyperglycemia in humans. Am Rev Respir Dis 1982; 125: 23–7